Advanced search×

The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.

Ahmed Elkashef, Richard A Rawson, Edwina Smith, Valerie Pearce, Frank Flammino, Jan Campbell, Roger Donovick, Charles Gorodetzky, William Haning, Joseph Mawhinney, Michael McCann, Dennis Weis, Lorie Williams, Walter Ling, and Frank Vocci

Addiction (2007) PMID 17493059

In order to increase the number of investigative teams and sites conducting research on pharmacological treatments for methamphetamine use disorders, the National Institute on Drug Abuse (NIDA) established an infrastructure of clinical sites in areas where methamphetamine addiction is prevalent. This multi-site infrastructure would serve to run multiple Phases II and III protocols effectively and expeditiously.

DOI: 10.1111/j.1360-0443.2007.01779.x
Version: za2963e q8zab q8zba q8zc5 q8zd3 q8zea q8zf5 q8zg1

Similar articles you may find interesting…

  1. Educational Paper: Aspects of clinical pharmacology in children—pharmacovigilance and safety
    Imti Choonara

    Eur J Pediatr 172(5):577-580 (2013) PMID 23111760

    Adverse drug reactions (ADRs) are a significant problem in children, affecting one in ten children in hospital. Within the community, one in 500 children will experience an adverse drug reaction each year. Pharmacovigilance has been useful in detecting suspected ADRs. However, most A...
  2. Children's Oncology Group's 2013 blueprint for research: Radiation oncology
    Thomas E Merchant, David Hodgson, and John A Kalapurakal

    Pediatr Blood Cancer 60(6):1037-1043 (2013) PMID 23255526

    Radiation therapy (RT) is used to treat children with CNS tumors, solid tumors or Hodgkin lymphoma. Pediatric radiation oncologists have provided critical input into the development and implementation of concepts for clinical trials to further define the modality's role and test newe...
  3. Children's Oncology Group's 2013 blueprint for research: Epidemiology
    Logan G Spector, Julie A Ross, and Andrew F Olshan

    Pediatr Blood Cancer 60(6):1059-1062 (2013) PMID 23255344

    Investigators worldwide have for over 40 years conducted case-control studies aimed at determining the causes of childhood cancer. The central challenge to conducting such research is the rarity of childhood cancer, thus many studies aggregate cases through clinical trials organizati...